XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023 $ 346,540 $ 9 $ 805,107 $ 9 $ (458,585)
Beginning Balance (In shares) at Dec. 31, 2023   87,227,132      
Issuance of common stock upon exercise of stock options (share)   4,862      
Issuance of common stock upon exercise of stock options, Amount 48   48    
Issuance of common stock upon release of restricted stock units, shares   157,724      
Unvested common stock forfeiture   (12,555)      
Share-based compensation expenses 12,644   12,644    
Unrealized loss on available-for-sale securities (14)     (14)  
Net Income (Loss) (62,412)       (62,412)
Ending Balance at Mar. 31, 2024 296,806 $ 9 817,799 (5) (520,997)
Ending Balance (In shares) at Mar. 31, 2024   87,377,163      
Beginning Balance at Dec. 31, 2023 346,540 $ 9 805,107 9 (458,585)
Beginning Balance (In shares) at Dec. 31, 2023   87,227,132      
Unrealized loss on available-for-sale securities (31)        
Net Income (Loss) (66,819)        
Ending Balance at Jun. 30, 2024 306,731 $ 9 832,148 (22) (525,404)
Ending Balance (In shares) at Jun. 30, 2024   87,692,916      
Beginning Balance at Mar. 31, 2024 296,806 $ 9 817,799 (5) (520,997)
Beginning Balance (In shares) at Mar. 31, 2024   87,377,163      
Issuance of common stock upon exercise of stock options (share)   22,151      
Issuance of common stock upon exercise of stock options, Amount 324   324    
Issuance of common stock upon release of restricted stock units, shares   211,635      
Unvested common stock forfeiture   (12,860)      
Share-based compensation expenses 13,052   13,052    
Unrealized loss on available-for-sale securities (17)     (17)  
Issuance of common stock pursuant to Employee Stock Purchase Plan, Shares   94,827      
Issuance of common stock pursuant to Employee Stock Purchase Plan, Amount 973   973    
Net Income (Loss) (4,407)       (4,407)
Ending Balance at Jun. 30, 2024 306,731 $ 9 832,148 (22) (525,404)
Ending Balance (In shares) at Jun. 30, 2024   87,692,916      
Beginning Balance at Dec. 31, 2024 502,751 $ 10 1,056,738 84 (554,081)
Beginning Balance (In shares) at Dec. 31, 2024   101,116,162      
Issuance of common stock upon release of restricted stock units, shares   238,354      
Unvested common stock forfeiture   (735)      
Share-based compensation expenses 12,893   12,893    
Unrealized loss on available-for-sale securities (136)     (136)  
Net Income (Loss) (35,996)       (35,996)
Ending Balance at Mar. 31, 2025 479,512 $ 10 1,069,631 (52) (590,077)
Ending Balance (In shares) at Mar. 31, 2025   101,353,781      
Beginning Balance at Dec. 31, 2024 502,751 $ 10 1,056,738 84 (554,081)
Beginning Balance (In shares) at Dec. 31, 2024   101,116,162      
Issuance of common stock upon exercise of stock options, Amount 0        
Unrealized loss on available-for-sale securities (176)        
Net Income (Loss) (66,318)        
Ending Balance at Jun. 30, 2025 460,834 $ 10 1,081,315 (92) (620,399)
Ending Balance (In shares) at Jun. 30, 2025   102,431,933      
Beginning Balance at Mar. 31, 2025 479,512 $ 10 1,069,631 (52) (590,077)
Beginning Balance (In shares) at Mar. 31, 2025   101,353,781      
Issuance of common stock upon exercise of stock options (share)   246,250      
Issuance of common stock upon release of restricted stock units, shares   142,258      
Share-based compensation expenses 10,936   10,936    
Unrealized loss on available-for-sale securities (40)     (40)  
Issuance of common stock pursuant to Employee Stock Purchase Plan, Amount 748   748    
Issuance of common stock upon exercise of warrants   689,644      
Net Income (Loss) (30,322)       (30,322)
Ending Balance at Jun. 30, 2025 $ 460,834 $ 10 $ 1,081,315 $ (92) $ (620,399)
Ending Balance (In shares) at Jun. 30, 2025   102,431,933